Evidence map›Paper›PMID 35360769›Full record

ArticleJournal of family medicine and primary care2022

Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications.

Siddhartha Dutta, Rimple J Kaur, Pankaj Bhardwaj, Sneha Ambwani, Brian Godman, Pallavi A Jha, Sanchi Sukhija, Suman S Venkatesh, Halyna Lugova, Salequl Islam and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Prescription-only medicine requests by clients: Insights from community pharmacies.Exploratory research in clinical and social pharmacy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 5 countries.

Siddhartha DuttaDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Rimple J KaurDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Pankaj BhardwajCommunity and Family Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Sneha AmbwaniDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Brian GodmanStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom.
Pallavi A JhaDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Sanchi SukhijaDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Suman S VenkateshDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Halyna LugovaUnit of Community Medicine, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, Kuala Lumpur, Malaysia.
Salequl IslamDepartment of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Jaykaran CharanDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Mainul HaqueUnit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, Kuala Lumpur, Malaysia.
All India Institute of Medical Sciences Jodhpur · INNational Defence University of Malaysia · MYJahangirnagar University · BDUniversiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 pandemic led to increased self-medication of antimicrobials, vitamins, and immune boosters among the common people and consuming without prescription can lead to adverse consequences including antimicrobial resistance. Methods: A cross-sectional study was conducted on community pharmacies in Jodhpur, India. They were inquired regarding the prescription and increased sales (<25%, 25-50%, 50--75%, or 75--100%) of various medicines (Hydroxychloroquine, Azithromycin, Ivermectin, and Vitamin C) during the COVID-19 pandemic. Logistic regression analysis was conducted to assess the relationship between requests for certain COVID-19 medications and an increase in their sale. Results: A total of 204 pharmacies took part, and 88.23% reported patients to approach them without prescriptions. Most of the pharmacies revealed that <25% of patients came without prescription. The majority came for azithromycin (68%) and vitamin C (92%). Increased sales of the four targeted medications were seen by 85.92% of pharmacies compared to last year. A majority (51.5%) reported <25% increased sales of azithromycin, but no change in the sale of hydroxychloroquine and ivermectin. However, 39.6% reported >75% increase in vitamin C sales. Conclusion: There was an increase in the demand for COVID-19 medications without prescription. This study was unable to detect a significant increase in sales of antimicrobials, which is encouraging.

Indexed as

Antimicrobialazithromycincommunity pharmacyCOVID-19hydroxychloroquineIndiavitamin C

Identifiers

PMID35360769
PMCPMC8963618
OpenAlexW3207880125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.